Acute pain in herpes zoster: the famciclovir database project

被引:39
作者
Dworkin, RH
Nagasako, EM
Johnson, RW
Griffin, DRJ
机构
[1] Univ Rochester, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA
[2] Univ Bristol, Dept Anesthesiol, Bristol, Avon, England
[3] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[4] SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England
关键词
herpes zoster; postherpetic neuralgia; acute pain; chronic pain; risk factors;
D O I
10.1016/S0304-3959(01)00347-5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The results of a considerable number of recent prospective studies have demonstrated that greater acute pain severity in herpes zoster patients is associated with a significantly greater risk of developing postherpetic neuralgia (PHN). Only a few studies have examined the relationships between acute pain severity and demographic characteristics and clinical features of patients with herpes zoster, however, and the results of these studies have been inconsistent. To clarify these relationships, data from 1778 herpes zoster patients studied within 72 h of rash onset in four clinical trials of the antiviral agent famciclovir were examined, Univariate and multivariate analyses indicated that greater acute pain severity was significantly associated with greater age, female sex, greater rash severity, the presence of a prodrome, and primary involvement of non-trigeminal dermatomes. These results demonstrate that three of the established risk factors for PHN - older age, greater rash severity, and the presence of a prodrome - are also associated with more severe acute pain assessed soon after rash onset in patients with herpes zoster. The results of this study are consistent with the recommendation that herpes zoster patients who are older, who have had a prodrome, or who have severe rash or severe acute pain should be targeted for interventions designed to prevent PHN. (C) 2001 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 54 条
[1]  
ASHTON RE, 1996, EUR C ANT CHEM GLASG
[2]  
BALFOUR HH, 1988, AM J MED, V85, P68
[3]  
BAMFORD JAC, 1968, MED J AUSTRALIA, V13, P524
[4]   Afferent large fiber polyneuropathy predicts the development of postherpetic neuralgia [J].
Baron, R ;
Haendler, G ;
Schulte, H .
PAIN, 1997, 73 (02) :231-238
[5]   HYPOTHESES ON THE PATHOGENESIS OF HERPES ZOSTER-ASSOCIATED PAIN [J].
BENNETT, GJ .
ANNALS OF NEUROLOGY, 1994, 35 :S38-S41
[6]   VALACICLOVIR COMPARED WITH ACYCLOVIR FOR IMPROVED THERAPY FOR HERPES-ZOSTER IN IMMUNOCOMPETENT ADULTS [J].
BEUTNER, KR ;
FRIEDMAN, DJ ;
FORSZPANIAK, C ;
ANDERSEN, PL ;
WOOD, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1546-1553
[7]  
BOON RJ, 1996, ANTIVIRAL CHEMOTHERA, V4, P17
[8]  
CANDAELE M, 1994, INT C ANT RES CHARL
[9]   Risk factors for postherpetic neuralgia [J].
Choo, PW ;
Galil, K ;
Donahue, JG ;
Walker, AM ;
Spiegelman, D ;
Platt, R .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1217-1224
[10]  
COBO LM, 1986, OPHTHALMOLOGY, V93, P763